Fairvalue-Calculator Fairvalue-Calculator
EN DE

TherapeuticsMD, Inc (TXMD) Fair Value & Analysis

Healthcare · US · Market cap $23.1M

Price$2.01
Fair Value$0.9000
Upside-55.2%
Quality95/100
Evidence: Low Range $0.6700 – $1.14

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

TherapeuticsMD, Inc (TXMD) currently trades at $2.01, while our model-based Fair Value estimate is $0.9000 — implying the stock looks roughly 55.2% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +885% Jiangsu Hengrui Pharmaceuticals Co (600276) -44% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -75% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -78%

Frequently asked questions

Is TherapeuticsMD, Inc (TXMD) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $0.9000 versus a price of $2.01 — about −55% (overvalued). Model-based estimate, not financial advice.
What is the fair value of TXMD?
Our 21-model fair value for TherapeuticsMD, Inc is $0.9000 (as of Jun 25, 2026), built from audited fundamentals. The current price is $2.01.
What is the quality score of TXMD?
TherapeuticsMD, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.